Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the beginning of 2018. Several of the CTS client forms specify list the Medical Director in the header and these forms will be updated on March 5, 2018. Check out the Communication page for a complete list of forms or by clicking the link below: Communications
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...